Cingulate, Indegene to Participate in Benzinga All Live Access Event
12 mai 2023 15h45 HE
|
Cingulate Inc.
KANSAS CITY, Kan., May 12, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301
13 mars 2023 06h45 HE
|
Cingulate Inc.
Go-to-Market Solution Provides Full Commercial Support for the First, True Entire Active-Day Medication Designed to treat ADHD Indegene Model Geared for Efficient National Commercial Launch in...
Everest Group recognizes Indegene as a Leader in its Life Sciences Commercial Services Specialists PEAK Matrix® Assessment 2022
18 janv. 2022 06h30 HE
|
Indegene Inc
PRINCETON, N.J., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Everest Group, a leading global research firm recognized Indegene as a Leader in its first-ever Life Sciences Commercial Services Specialists PEAK...
Indegene refreshes its brand to align with its purpose - To enable healthcare organizations be future ready
30 juin 2021 08h35 HE
|
Indegene Inc
PRINCETON, N.J., June 30, 2021 (GLOBE NEWSWIRE) -- Indegene, a technology-led healthcare solutions provider, today announced its new brand expression, aligned with its purpose to enable healthcare...
Indegene and ConTIPI Medical Ltd partner to bring innovative disposable non-surgical device to market to help women suffering from Pelvic Organ Prolapse (POP)
03 mars 2021 09h00 HE
|
Indegene Inc
PRINCETON, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Indegene, a global enterprise healthtech solutions company and ConTIPI Medical Ltd, an innovator in the field of providing non-surgical and...
Carlyle and Brighton Park agree to invest US$200 million in Indegene
02 févr. 2021 13h31 HE
|
Indegene Inc; Carlyle Group; Brighton Park Capital
BANGALORE, India and PRINCETON, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) -- The Carlyle Group (NASDAQ: CG), Brighton Park Capital and Indegene, the Bangalore-headquartered enterprise healthtech...
Alfasigma USA, Inc. Engages Indegene, Inc. to Expand the Promotion of ZELNORM® to Healthcare Professionals in the United States
23 juil. 2020 09h30 HE
|
Indegene Inc
BEDMINSTER, N.J., July 23, 2020 (GLOBE NEWSWIRE) -- Alfasigma USA, Inc. today announced a strategic deal with Indegene, Inc., a global life sciences and healthcare solutions provider, to co-promote...